Man Held With 200 Banned Injections Awarded 12-Year Jail Term

Chandigarh : The Chandigarh district court has sentenced a man arrested with 200 banned injections to 12 years of rigorous imprisonment.

The special court judge Rajiv K Beri also imposed a ₹1.20 lakh fine on Yadwinder Singh, who was convicted under Section 22 (c) of the Narcotic Drugs and Psychotropic Substances (NDPS) Act.

According to the prosecution, a police team was on patrolling duty near the Electricity Office, in Sector 41, on February 15, 2018 when around 9.30 pm they saw the accused walking towards them with a yellow polythene bag in his right hand. But on spotting the police, he panicked and started walking away.

On frisking him, the cops found 100 injections of buprenorphine (2 ml each) and 100 injections of pheniramine maleate (10 ml each) in his possession. As Singh could not produce any permit for the injections, he was booked under Section 22 of the Narcotic Drugs and Psychotropic Substances (NDPS) Act.

The defence counsel submitted that the accused was falsely implicated, and was shown to be arrested from Chandigarh, which was incorrect.

Holding the accused guilty, the court observed, “The nature of offence and recovery of multi-times commercial quantity of 198.8 g of contraband containing buprenorphine from the conscious possession of the convict does not leave any reason with the court to treat him with leniency.”

“It may give the wrong signal to society, thereby, encouraging propagation of delivery and possession of such psychotropic substances which are hazardous, damaging and are potential reasons for spoiling youth,” the court added in its order dated August 23.

  • Related Posts

    • Pharma
    • December 23, 2024
    • 63 views
    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    India’s healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According…

    • Pharma
    • December 23, 2024
    • 91 views
    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 65 new drug formulations and notified ceiling price fixation of 13 formulations. The regulatory body, under the Department of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt